Christel Franchet

Christel Franchet has over 25 years of experience in the biopharmaceutical industry. Christel began their career in 1994 as a Post-Doctorant at F.Hoffmann-La Roche. In 1999, they became an Ingénieur de recherche à la valorisation at CNRS UPR 9050, where they were responsible for miniaturization and automation of FRET-based binding assays on GPCRs. Christel also co-founded Euroclide in 2001, where they served as a Senior Scientist. In 2003, they began working at Faust Pharmaceuticals as a Platform Supervisor, where they were responsible for pharmacological assays design. In 2008, Faust Pharmaceuticals became Domain Therapeutics, where Christel served as the Head of the Biology Department. In this role, they were responsible for in vitro R&D lab, pharmacological assays design, binding, and functional assays.

Christel Franchet attended the University of Strasbourg from 1990 to 1994, where they obtained a Doctorat de Biologie Moléculaire et cellulaire (option: neurobiologie). Christel then returned to the University of Strasbourg in 1998 and obtained a Diplôme d’investigateurs aux essais cliniques des médicaments in 1999. No additional certifications are listed.